C.M. Bidwell & Associates’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,305
| Closed | -$40K | – | 598 |
|
|
2021
Q4 | $40K | Buy |
+5,305
| New | +$40K | 0.02% | 319 |
|
|
2021
Q2 | – | Sell |
-12,401
| Closed | -$155K | – | 616 |
|
|
2021
Q1 | $155K | Buy |
12,401
+1,651
| +15% | +$20.6K | 0.11% | 173 |
|
|
2020
Q4 | $168K | Buy |
10,750
+7,135
| +197% | +$112K | 0.14% | 144 |
|
|
2020
Q3 | $34K | Buy |
+3,615
| New | +$34K | 0.03% | 284 |
|